Strategic Prevention Framework for Prescription Drugs

Short Title: 
SPF Rx
Initial Announcement
Funding Opportunity Announcement (FOA) Information
FOA Number: 
SP-16-006
Posted on Grants.gov: 
Tuesday, March 29, 2016
Application Due Date: 
Tuesday, May 31, 2016
Catalog of Federal Domestic Assistance (CFDA) Number: 
93.243
Description

The SPF Rx grant program provides an opportunity for states, U.S. territories, pacific jurisdictions (herein referred to as “states”), and tribal entities that have completed a Strategic Prevention Framework State Incentive Grant (SPF SIG) to target the priority issue of prescription drug misuse. The program is designed to raise awareness about the dangers of sharing medications and work with pharmaceutical and medical communities on the risks of overprescribing to young adults. SPF Rx will also raise community awareness and bring prescription drug abuse prevention activities and education to schools, communities, parents, prescribers, and their patients. In addition, SAMHSA will track reductions in opioid overdoses and the incorporation of Prescription Drug Monitoring Program (PDMP) data into needs assessments and strategic plans as indicators of the program’s success.

PDMPs are state-run databases used to track the prescribing and dispensing of controlled prescription drugs to patients. They are designed to monitor this information for suspected abuse or diversion (i.e., channeling drugs into illegal use), and can give a prescriber or pharmacist critical information regarding a patient’s controlled substance prescription history. State applicants must have a fully operational PDMP in order to apply for the SPF Rx program. Tribes must coordinate with the state run PDMPs to identify opportunities for collaboration that will limit overprescribing in tribal communities.

Eligibility

Eligibility is limited to states, U.S. territories, pacific jurisdictions (herein referred to as “states”), and tribal entities that have completed a Strategic Prevention Framework State Incentive Grant (SPF SIG). Applicants also are required to have an operational state run PDMP. See Table 2 in the FOA for a complete list of eligible applicants. Applications received from any other entity will be screened out and will not be reviewed.

Award Information
Funding Mechanism: 
Cooperative Agreement
Anticipated Total Available Funding: 
$9,290,395
Anticipated Number of Awards: 
25
Anticipated Award Amount: 
Up to $371,616 per year
Length of Project: 
Up to five years
Cost Sharing/Match Required?: 
No

Proposed budgets cannot exceed $371,616 in total costs (direct and indirect) in any year of the proposed project. Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.

Contact Information
Program Issues

Kim Nesbitt, MA
Division of State Programs 
Center for Substance Abuse Prevention 
Substance Abuse and Mental Health Services Administration 
5600 Fishers Lane, Room 16E65A
Rockville, MD  20857
240-276-1742
410-496-9913 (Fax)
kim.nesbitt@samhsa.hhs.gov

Kemar Mapp, MPH
Public Health Advisor 
SAMHSA/CSAP/DSP
5600 Fishers Lane, Room 16E26D
Rockville, MD  20857 
240-276-1241
301-480-8480 (Fax)
kemar.mapp@samhsa.hhs.gov

Grants Management and Budget Issues

Eileen Bermudez
Office of Financial Resources, Division of Grants Management
Substance Abuse and Mental Health Services Administration
5600 Fishers Lane, Room 
Rockville, Maryland  20857
240-276-1412
foacsap@samhsa.hhs.gov

Application Materials

You must respond to the requirements in both the FOA PART I and PART II when preparing your application.

Useful Information for Applicants

Last Updated: 03/29/2016